Impact of conversion surgery on survival in locally advanced pancreatic cancer patients treated with FOLFIRINOX chemotherapy.
Mirang LeeJae-Seung KangHongbeom KimWooil KwonSang Hyub LeeJi-Kon RyuYong-Tae KimDo-Youn OhEui Kyu ChieJin-Young JangPublished in: Journal of hepato-biliary-pancreatic sciences (2021)
Conversion surgery after FOLFIRINOX chemotherapy effectively rescues patients with LAPC. Patients without progression after FOLFIRINOX could be considered as potential candidates for conversion surgery.